Oncogenes and tumor suppressor genes in human malignancies
著者
書誌事項
Oncogenes and tumor suppressor genes in human malignancies
(Cancer treatment and research, v. 63)
Kluwer Academic Publishers, 1993
大学図書館所蔵 全10件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The first edition of Oncogenes (1989) focused on several of the better known transforming mechanisms and surveyed a spectrum of solid tumors and hematologic malignancies. Several of the nearly 50 known oncogenes most relevant to human disease were examined. In contrast, this volume presents a very different profile and balance of subject material that reflects the rapidly changing field of molecular oncology and its newly emerging concepts. Among the most important discoveries of the past 4 years are the identification of nearly a dozen different tumor suppressor genes and the finding of an entirely new class of cancer-causing gene (bcl-2) that acts by inhibiting cell death rather than stimulating cell proliferation. This edition begins by reviewing selected malignancies in which our earlier search for clinically relevant oncogenes has led to more focused studies on gain-of-function and loss-of-function genetic abnormalities, as well as autocrine and paracrine growth factor loops known to regulate tumor physiology and malignant cell behavior. Curiously, many of these genetic and functional abnormalities are shared by several different tumor types and are not uniformly present in all tumors of the same type. This observation brings up molecular questions about the tissue-specific determinants that underlie individual cancers and also gives added impetus to the suggestion that molecular abnormalities (referred to as tumor markers) be included among the histopathologic features used for clinical diagnosis and manage ment.
目次
- Preface. 1. Oncogenes and Tumor Suppressor Genes
- E. Liu, B. Weissman. 2. Activated Oncogenes and Putative Tumor Suppressor Genes involved in Human Breast Cancers
- D. Tripathy, C. Benz. 3. Oncogenes in Human Lung Cancer
- R.A. Kratzke, E. Shimizu, F.J. Kaye. 4. Thyroid Growth Factors and Oncogenes
- O. Clark, Q.-Y. Duh. 5. Growth Regulation of Human Neuroblastoma
- O. El-Badney, M. Israel. 6. Kaposi's Sarcoma: a Cytokine Responsive Neoplasia? S. Miles. 7. BCL-2: Physiology and Role in Neoplasia
- A. Bagg, J. Cossman. 8. Malignant Transformation by abl and BCR/ABL
- R. van Etten. 9. The Biological and Clinical Role of Increased Insulin Receptors in Human Breast Cancer
- R. Vigneri, I. Goldfine. 10. The Role of Fibroblast Growth Factors and Related Oncogenes in Tumor Growth
- H. Brem, M. Klagsbrun. 11. Transforming Growth Factor-alpha and its Role in Neoplastic Progression
- D. Lee, N.C. Luetteke, L.A. Petch. 12. Growth Regulation by Transforming Growth Factor-beta
- B. Arrick, R. Derynck. 13. Signal Transduction by Receptor Tyrosine Kinases
- D. Kaplan, D. Morrison. 14. Involvement of G-Proteins, Cytoplasmic Calcium, Phospholipases, Phospholipid-derived Second Messengers, and Protein Kinases in Signal Transduction from Mitogenic Cell Surface Receptors
- R. Frye. 15. Fos and Jun Inducible Transcription Factors Regulating Growth of Normal and Transformed Cells
- J. Holt. 16. DNA Binding by the Myc Oncoproteins
- G.J. Kato, D.W. Wechsler, C.V. Dang. 17. Normal and Malignant Growth Control by p53
- C. Finlay 18. Nucleoside Diphosphate Kinases, nm23 and Tumor Metastasis: Possible Biochemical Mechanisms
- A. Golden, M. Benedict, A. Shearn. N.Kimura, A. Leone, L. Liotta P. Steeg 19. Angiogenesis: a Mechanism by which Oncogenes Regulate Tumorigenesis
- N. Bouck. Index.
「Nielsen BookData」 より